The GYF domain is a novel structural fold that is involved in lymphoid signaling through proline-rich sequences

被引:81
作者
Freund, C [3 ]
Dötsch, V
Nishizawa, K
Reinherz, EL
Wagner, G
机构
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Immunobiol Lab, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA
基金
美国国家科学基金会; 美国国家卫生研究院;
关键词
D O I
10.1038/10712
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
T cell activation through the CD2 cell surface receptor is transmitted by proline-rich sequences within its cytoplasmic tail. A membrane-proximal proline-rich tandem repeat, involved in cytokine production, is recognized by the intracellular CD2 binding protein CD2BP2. We solved the solution structure of the CD2 binding domain of CD2BP2, which we name the glycine-tyrosine-phenylalanine (GYF) domain. The GYF sequence is part of a structurally unique bulge-helix-bulge motif that constitutes the major binding site for the CD2 tail. A hydrophobic surface patch is created by motif residues that are highly conserved among a variety of proteins from diverse eukaryotic species. Thus, the architecture of the GYF domain may be widely used in protein-protein associations.
引用
收藏
页码:656 / 660
页数:5
相关论文
共 36 条
[1]   Gapped BLAST and PSI-BLAST: a new generation of protein database search programs [J].
Altschul, SF ;
Madden, TL ;
Schaffer, AA ;
Zhang, JH ;
Zhang, Z ;
Miller, W ;
Lipman, DJ .
NUCLEIC ACIDS RESEARCH, 1997, 25 (17) :3389-3402
[2]   H-1-H-1 CORRELATION VIA ISOTROPIC MIXING OF C-13 MAGNETIZATION, A NEW 3-DIMENSIONAL APPROACH FOR ASSIGNING H-1 AND C-13 SPECTRA OF C-13-ENRICHED PROTEINS [J].
BAX, A ;
CLORE, GM ;
GRONENBORN, AM .
JOURNAL OF MAGNETIC RESONANCE, 1990, 88 (02) :425-431
[3]   THE (YXXL/I)(2) SIGNALING MOTIF FOUND IN THE CYTOPLASMIC SEGMENTS OF THE BOVINE LEUKEMIA-VIRUS ENVELOPE PROTEIN AND EPSTEIN-BARR-VIRUS LATENT MEMBRANE PROTEIN-2A CAN ELICIT EARLY AND LATE LYMPHOCYTE-ACTIVATION EVENTS [J].
BEAUFILS, P ;
CHOQUET, D ;
MAMOUN, RZ ;
MALISSEN, B .
EMBO JOURNAL, 1993, 12 (13) :5105-5112
[4]   Structure and mechanism of DNA topoisomerase II [J].
Berger, JM ;
Gamblin, SJ ;
Harrison, SC ;
Wang, JC .
NATURE, 1996, 379 (6562) :225-232
[5]  
BIERER BE, 1989, ANNU REV IMMUNOL, V7, P579, DOI 10.1146/annurev.iy.07.040189.003051
[6]   CD2 IS INVOLVED IN MAINTENANCE AND REVERSAL OF HUMAN ALLOANTIGEN-SPECIFIC CLONAL ANERGY [J].
BOUSSIOTIS, VA ;
FREEMAN, GJ ;
GRIFFIN, JD ;
GRAY, GS ;
GRIBBEN, JG ;
NADLER, LM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (05) :1665-1673
[7]  
Brunger AT, 1992, XPLOR VERSION 3 1 MA
[8]   DISSECTION OF THE HUMAN-CD2 INTRACELLULAR DOMAIN - IDENTIFICATION OF A SEGMENT REQUIRED FOR SIGNAL TRANSDUCTION AND INTERLEUKIN-2 PRODUCTION [J].
CHANG, HC ;
MOINGEON, P ;
LOPEZ, P ;
KRASNOW, H ;
STEBBINS, C ;
REINHERZ, EL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (06) :2073-2083
[9]   INVOLVEMENT OF THE PPPGHR MOTIF IN T-CELL ACTIVATION VIA CD2 [J].
CHANG, HC ;
MOINGEON, P ;
PEDERSEN, R ;
LUCICH, J ;
STEBBINS, C ;
REINHERZ, EL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (01) :351-355
[10]   A novel adaptor protein orchestrates receptor patterning and cytoskeletal polarity in T-cell contacts [J].
Dustin, ML ;
Olszowy, MW ;
Holdorf, AD ;
Li, J ;
Bromley, S ;
Desai, N ;
Widder, P ;
Rosenberger, F ;
van der Merwe, PA ;
Allen, PM ;
Shaw, AS .
CELL, 1998, 94 (05) :667-677